March 22, 2021
Read this article
By Thomas Brown, MD
Inaugural Real World Dialogue kicked off with industry heavyweight Dr. Leroy (Lee) Hood sharing his perspective on how real-world evidence will evolve over the years and its potential to end suffering from cancer and other health challenges.
By Vinod Subramanian
Syapse made its presence known in the precision medicine and real-world evidence space over a decade ago. In this time, the use and understanding of how real-world data can impact patient care has evolved through technology, research and policy. Staying at the forefront of this work remains critical to our growth. By being a part of the larger digi…
By Ken Tarkoff
Three essential challenges we must overcome in order to leverage real-world evidence to impact patient care, and how the ongoing pandemic will continue to shape our approaches to surmounting these challenges.
By Betty Mbom, PhD
Clinical research serves to grow our understanding of how to best diagnose and treat cancer. For diseases such as testicular cancer and pediatric leukemia, steady increases in survival rates continue due to advancements in clinical research; while diseases such as melanoma and chronic myeloid leukemia are revolutionizing through breakthrough clin…
By Antoinette Cummins
Please fill out the form below to view the recording.
Syapse hosted its 3rd annual Precision Medicine Council to convene healthcare leaders to discuss applications for real-world insights and common challenges in delivering real-world care.
As a part of the council, we invited Dr. Amy Abernethy, Principal Deputy Commissioner of the FDA, to shar…
“Delays in screenings, diagnosis and treatment because of the coronavirus pandemic are likely to result in thousands of “excess” deaths from the disease in coming years.” Ned Sharpless, M.D., director of the National Cancer Institute
If you’d like to learn more about Syapse, tell us a little about yourself and we will reach out as soon as possible.